BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

91 related articles for article (PubMed ID: 1598823)

  • 1. Antagonism of l-stepholidine on D2 receptor-mediated inhibition of synaptosomal adenylate cyclase in rat corpus striatum.
    Hu G; Hu Y; Jin GZ
    Zhongguo Yao Li Xue Bao; 1992 Mar; 13(2):104-10. PubMed ID: 1598823
    [TBL] [Abstract][Full Text] [Related]  

  • 2. (-)-Stepholidine antagonizes the inhibition by D2 receptor agonists on synaptosomal tyrosine hydroylase in rat corpus striatum.
    Hu G; Jin GZ
    Zhongguo Yao Li Xue Bao; 1995 Jul; 16(4):376-9. PubMed ID: 7668115
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Characterization of dopamine receptors mediating inhibition of adenylate cyclase activity in rat striatum.
    Onali P; Olianas MC; Gessa GL
    Mol Pharmacol; 1985 Aug; 28(2):138-45. PubMed ID: 2410769
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Effects of l-stepholidine on synaptosomal Ca(2+)-ATPase and subcellular calmodulin in rat striatum.
    Hu G; Hu Y; Jin GZ
    Zhongguo Yao Li Xue Bao; 1992 Jul; 13(4):307-11. PubMed ID: 1456049
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Dual actions of (-)-stepholidine on the dopamine receptor-mediated adenylate cyclase activity in rat corpus striatum.
    Dong ZJ; Guo X; Chen LJ; Han YF; Jin GZ
    Life Sci; 1997; 61(4):465-72. PubMed ID: 9244373
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Effects of tetrahydroprotoberberines on dopamine receptor subtypes in brain.
    Xu SX; Yu LP; Han YR; Chen Y; Jin GZ
    Zhongguo Yao Li Xue Bao; 1989 Mar; 10(2):104-10. PubMed ID: 2530755
    [TBL] [Abstract][Full Text] [Related]  

  • 7. D2-dopamine receptor-mediated inhibition of cyclic AMP formation in striatal neurons in primary culture.
    Weiss S; Sebben M; Garcia-Sainz JA; Bockaert J
    Mol Pharmacol; 1985 Jun; 27(6):595-9. PubMed ID: 2987658
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Augmentation of dopamine release by (-)-stepholidine from rabbit and rat caudate slices.
    Dong ZJ; Jin GZ; Huang HY
    Zhongguo Yao Li Xue Bao; 1995 Nov; 16(6):497-501. PubMed ID: 8732041
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Dopamine, acting through D-2 receptors, inhibits rat striatal adenylate cyclase by a GTP-dependent process.
    Cooper DM; Bier-Laning CM; Halford MK; Ahlijanian MK; Zahniser NR
    Mol Pharmacol; 1986 Feb; 29(2):113-9. PubMed ID: 3005824
    [TBL] [Abstract][Full Text] [Related]  

  • 10. (-)-Stepholidine enhances K+ depolarization-induced activation of synaptosomal tyrosine 3-monooxygenase from rat striatum.
    Hu G; Wu YM; Jin GZ
    Zhongguo Yao Li Xue Bao; 1997 Jan; 18(1):49-52. PubMed ID: 10072893
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Presynaptic inhibition of dopamine synthesis in rat striatal tissue by enantiomeric mono- and dihydroxyaporphines.
    Booth RG; Baldessarini RJ; Kula NS; Gao Y; Zong R; Neumeyer JL
    Mol Pharmacol; 1990 Jul; 38(1):92-101. PubMed ID: 1973525
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Effects of clozapine on rat striatal muscarinic receptors coupled to inhibition of adenylyl cyclase activity and on the human cloned m4 receptor.
    Olianas MC; Maullu C; Onali P
    Br J Pharmacol; 1997 Oct; 122(3):401-8. PubMed ID: 9351494
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Mu- and delta-opioid receptor-mediated inhibition of adenylate cyclase activity stimulated by released endogenous dopamine in rat neostriatal slices; demonstration of potent delta-agonist activity of bremazocine.
    Heijna MH; Hogenboom F; Portoghese PS; Mulder AH; Schoffelmeer AN
    J Pharmacol Exp Ther; 1989 Jun; 249(3):864-8. PubMed ID: 2543814
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Dopamine-glutamate interaction in rat striatal slices: changes of CCDPK II, PKA, and LDH activity by receptor-mediated mechanisms.
    Tang FM; Sun YF; Wang R; Ding YM; Zhang GY; Jin GZ
    Acta Pharmacol Sin; 2000 Feb; 21(2):145-50. PubMed ID: 11263261
    [TBL] [Abstract][Full Text] [Related]  

  • 15. [Differential regulation of dopamine receptors on pre- and postsynaptic Na+, K(+)-ATPase in rat striatum].
    Hu G; Qin W
    Yao Xue Xue Bao; 1997 Apr; 32(4):241-4. PubMed ID: 11499023
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Electrophysiological study on biphasic firing activity elicited by D(1) agonistic-D(2) antagonistic action of (-)-stepholidine in nucleus accumbens.
    Zhu ZT; Fu Y; Hu GY; Jin GZ
    Sheng Li Xue Bao; 2000 Apr; 52(2):123-30. PubMed ID: 11961581
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Effects of l-stepholidine on tyrosine hydroxylase activity in rat corpus striatum.
    Guo X; Chen LJ; Buda M; Jin GZ
    Zhongguo Yao Li Xue Bao; 1992 Jul; 13(4):289-92. PubMed ID: 1360740
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Chronic treatment with (-)-stepholidine alters density and turnover of D1 and D2 receptors in striatum.
    Zou LL; Cai ST; Jin GZ
    Zhongguo Yao Li Xue Bao; 1996 Nov; 17(6):485-9. PubMed ID: 9863137
    [TBL] [Abstract][Full Text] [Related]  

  • 19. I-stepholidine facilitates inhibition of mPFC DA receptors on subcortical NAc DA release.
    Zhu ZT; Wu WR; Fu Y; Jin GZ
    Acta Pharmacol Sin; 2000 Jul; 21(7):663-7. PubMed ID: 11360679
    [TBL] [Abstract][Full Text] [Related]  

  • 20. BW373U86: a nonpeptidic delta-opioid agonist with novel receptor-G protein-mediated actions in rat brain membranes and neuroblastoma cells.
    Childers SR; Fleming LM; Selley DE; McNutt RW; Chang KJ
    Mol Pharmacol; 1993 Oct; 44(4):827-34. PubMed ID: 8232233
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 5.